Research statistics

AOD-9604 research: publications and trials

What has been published on AOD-9604: PubMed publications, the kind of evidence they report and registered clinical trials. These are counts of research, not a judgment of whether AOD-9604 works or is safe. For what it is and what the studies found, see the AOD-9604 profile.
Automated weekly refresh · data through November 15, 2026

At a glance

Publications, all years

14

Since 2000

Publications in 2026 so far

3

Through November 15, 2026

Human clinical research

0.0%

0 of 14 classified

Registered clinical trials

0

ClinicalTrials.gov

Randomized controlled trials

0

Publications reporting an RCT in people

Systematic reviews and meta-analyses

0

Preclinical studies

50.0%

4 animal · 3 in vitro · 0 computational

Records that only mention it

9

Not counted above

Status in the library: Research only. Groups: Growth hormone axis.

What to keep in mind

  • No human clinical publication is indexed: everything published so far is preclinical, a review or commentary.
  • Fewer than three randomized controlled trials are indexed.
  • Fewer than 25 publications are indexed, so year-to-year changes are not meaningful.

Publications by year

AOD-9604 publications by year and evidence

2000, Preclinical (animal, in vitro, computational): 1 of 12001, Preclinical (animal, in vitro, computational): 2 of 22004, Reviews and meta-analyses: 1 of 12006, Reviews and meta-analyses: 1 of 12013, Other and not yet classified: 1 of 12014, Preclinical (animal, in vitro, computational): 1 of 22014, Other and not yet classified: 1 of 22015, Preclinical (animal, in vitro, computational): 2 of 32015, Reviews and meta-analyses: 1 of 32026 (to date), Preclinical (animal, in vitro, computational): 1 of 32026 (to date), Reviews and meta-analyses: 2 of 3Preclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classified01232000200420132026*
Counted PubMed publications by year of first publication. * 2026 runs to November 15, 2026. A larger bar is more publications, not stronger evidence.
Show the data
YearPreclinical (animal, in vitro, computational)Reviews and meta-analysesOther and not yet classifiedTotal
20001001
20012002
20040101
20060101
20130011
20141012
20152103
2026 (to date)1203

Study types

Review5
Animal study4
In vitro study3
Editorial, letter or other2

Research areas

From MeSH major topics. A paper can be in several areas.

Metabolic health5
Obesity and weight management5
Endocrinology2
Musculoskeletal2
Immune system1
Tissue repair1

Registered clinical trials

A registration is not a result.

No registered trials.

Human trials and evidence reviews

Meta-analyses, systematic reviews and trials in people, newest first.

No human trial, systematic review or meta-analysis of AOD-9604 is indexed.

Most cited

By OpenAlex citation count. Citations measure attention, not quality or correctness.

  1. Obesity drugs in clinical development.

    Current opinion in investigational drugs (London, England : 2000) · April 1, 2006 · Review · cited 79 times

    PMID 16625817 · Reviews and meta-analyses

  2. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.

    Journal of separation science · December 15, 2015 · In vitro study · cited 48 times

    PMID 26578461 · DOI 10.1002/jssc.201501060 · In vitro studies

  3. Human sports drug testing by mass spectrometry.

    Mass spectrometry reviews · July 24, 2015 · Review · cited 43 times

    PMID 26213263 · DOI 10.1002/mas.21479 · Reviews and meta-analyses

  4. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment.

    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity · October 1, 2001 · Animal study · cited 36 times

    PMID 11673763 · DOI 10.1038/sj.ijo.0801740 · Animal studies

  5. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.

    Endocrinology · December 1, 2001 · Animal study · cited 31 times · open access

    PMID 11713213 · DOI 10.1210/endo.142.12.8522 · Animal studies

Latest publications

  1. Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices.

    The Analyst · July 27, 2026 · In vitro study · cited 0 times

    PMID 42328738 · DOI 10.1039/d6an00455e · In vitro studies

  2. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.

    Frontiers in endocrinology · June 18, 2026 · Review · cited 1 times · open access

    PMID 42395176 · DOI 10.3389/fendo.2026.1822475 · Reviews and meta-analyses

  3. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

    Sports medicine (Auckland, N.Z.) · April 12, 2026 · Review · cited 8 times · open access

    PMID 41966639 · DOI 10.1007/s40279-026-02437-0 · Reviews and meta-analyses

  4. Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.

    Journal of separation science · December 15, 2015 · In vitro study · cited 48 times

    PMID 26578461 · DOI 10.1002/jssc.201501060 · In vitro studies

  5. Human sports drug testing by mass spectrometry.

    Mass spectrometry reviews · July 24, 2015 · Review · cited 43 times

    PMID 26213263 · DOI 10.1002/mas.21479 · Reviews and meta-analyses

  6. Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.

    Annals of clinical and laboratory science · January 1, 2015 · Animal study · cited 8 times

    PMID 26275694 · Animal studies

  7. Detection and in vitro metabolism of AOD9604.

    Drug testing and analysis · September 10, 2014 · In vitro study · cited 12 times

    PMID 25208511 · DOI 10.1002/dta.1715 · In vitro studies

  8. Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604.

    Drug testing and analysis · June 26, 2014 · Editorial, letter or other · cited 15 times

    PMID 24976118 · DOI 10.1002/dta.1687 · Commentary and other

  9. AOD-9604 does not influence the WADA hGH isoform immunoassay.

    Drug testing and analysis · September 30, 2013 · Editorial, letter or other · cited 9 times

    PMID 24124033 · DOI 10.1002/dta.1557 · Commentary and other

  10. Obesity drugs in clinical development.

    Current opinion in investigational drugs (London, England : 2000) · April 1, 2006 · Review · cited 79 times

    PMID 16625817 · Reviews and meta-analyses

Browse all 14 publications in the dashboard

How this is counted

PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology

Search terms: AOD-9604; Tyr-hGH 177–191

((TITLE_ABS:"AOD-9604" OR CHEM:"AOD-9604" OR TITLE_ABS:"AOD9604" OR CHEM:"AOD9604") OR (TITLE_ABS:"Tyr-hGH 177–191" OR CHEM:"Tyr-hGH 177–191" OR TITLE_ABS:"Tyr-hGH177–191" OR CHEM:"Tyr-hGH177–191")) AND SRC:MED

Cite this page

Peptide Library. (2026, November 16). AOD-9604 research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/aod-9604